ALKTERNATE: A Pilot Study Alternating Lorlatinib with Crizotinib in Patients with ALK plus NSCLC and ALK-inhibitor Resistance
JOURNAL OF THORACIC ONCOLOGY(2023)
关键词
ALK NSCLC,Drug resistance,Clonal selection
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要